Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 337

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 337
---
ali in its valuation analysis are set forth in the table below:

|                             |     | FY2024 |            |   |     | FY2025 |             |   |     | FY2026 |             |   |     | FY2027 |             |   |     | FY2028 |             |     | FY2029 |               |     | FY2030 |               |     | FY2031 |               |     | FY2032 |               |     | FY2033 |               |
|:----------------------------|:----|:-------|-----------:|:--|:----|:-------|------------:|:--|:----|:-------|------------:|:--|:----|:-------|------------:|:--|:----|:-------|------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|
| Gross Sales(1)              |     | $      |          — |   |     | $      |           — |   |     | $      |           — |   |     | $      |  55,772,493 |   |     | $      | 449,647,912 |     | $      | 1,561,901,414 |     | $      | 4,062,790,900 |     | $      | 4,875,632,300 |     | $      | 5,141,859,100 |     | $      | 5,331,616,500 |
| Cost of Sales(2)            |     | $      |          — |   |     | $      |           — |   |     | $      |           — |   |     | $      |   5,577,249 |   |     | $      |  44,964,791 |     | $      |   156,190,141 |     | $      |   406,279,090 |     | $      |   487,563,230 |     | $      |   514,185,910 |     | $      |   533,161,501 |
| Gross Profit(3)             |     | $      |          — |   |     | $      |           — |   |     | $      |           —